The use of the calculated panel-reactive antibody and virtual crossmatch in heart transplantation

Current Opinion in Organ Transplantation

Volumn 17, Issue 4, 2012, Pages 423-426

  Chang, David ^a   Kobashigawa, Jon ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

calculated panel reactive antibody; histocompatibility; human leukocyte antigens; virtual crossmatch

Indexed keywords

BORTEZOMIB; COMPLEMENT COMPONENT C1Q; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PANEL REACTIVE ANTIBODY; RITUXIMAB;

AMYLOIDOSIS; ANTIBODY DETECTION; BLOOD GROUP TYPING; CARDIAC ALLOGRAFT VASCULOPATHY; DESENSITIZATION; DONOR SELECTION; GRAFT DYSFUNCTION; HEART ASSIST DEVICE; HEART GRAFT; HEART TRANSPLANTATION; PLASMAPHERESIS; POSTOPERATIVE INFECTION; REVIEW; SEPSIS; TREATMENT OUTCOME;

ANTIBODIES; COMPLEMENT C1Q; DESENSITIZATION, IMMUNOLOGIC; HEART DISEASES; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES;

EID: 84863828362     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328355f195     Document Type: Review

References (21)

1. Stehlik J, Edwards LB, Kucheryavaya A, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report-2011. J Heart Lung Transplant 2011; 30:1078-1094.
2. Kobashigawa J, MehraM, West L, et al. Report from a Consensus Conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant 2009; 28:213-225.
3. Hooper DK, Hawkins JA, Fuller TC, et al. Panel-reactive antibodies late after allograft implantation in children. Ann Thorac Surg 2005; 79:641-644.
4. Reed EF, Demetris AJ, Hammond E, et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006; 25:153-159.
5. Itescu S, Tung TC, Burke EM, et al. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for highgrade cellular rejection in recipients of heart transplantation. Circulation 1998; 98:786-793.
6. Nwakanma LU, Williams JA, Weiss ES, et al. Influence of pretransplant panelreactive antibody on outcomes in 8160 heart transplant recipients in recent era. Ann Thorac Surg 2007; 84:1556-1562.
7. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280:735-739.
8. Eng SE, Leffell S. Histocompatibility testing after fifty years of transplantation. J Immunol Methods 2011; 369:1-21.
9. Pei R, Lee JH, Shih NJ, et al. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003; 75:43-49.
10. Stastny P, Salvador IM, Lavingia B. Evaluation of the highly sensitized transplant recipient. Pediatr Nephrol 2011; 26:1927-1935.
11. Cecka JM. Calculated PRA (cPRA): the new measure of sensitization for transplant candidates. Am J Transplant 2009; 10:26-29.
12. Bray RA, Nolen JD, Larsen C, et al. Transplanting the highly sensitized patient: the Emory algorithm. Am J Transplant 2006; 6:2307-2315.
13. Stehlik J, Islam N, Hurst D, et al. Utility of virtual crossmatch in sensitized patients awaiting heart transplantation. J Heart Lung Transplant 2009; 28:1129-1134.
14. Chin C, Chen G, Sequeria F, et al. Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant 2011; 30:158-163.
15. George I, Colley P, Russo MJ, et al. Association of device surface and biomaterials with immunologic sensitization after mechanical support. J Thorac Cardiovasc Surg 2008; 135:1372-1379.
16. Arnaoutakis GJ, George T, Kilic A, et al. Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort. J Thorac Cardiovasc Surg 2011; 142:1236-1243.
17. John R, Lietz K, Burke E, et al. Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. Circulation 1999; 100:II229-II235.
18. Pisani VA, Mullen GM, Malinowska K, et al. Plasmapheresis with intravenous immunoglobulinGis effective in patients with elevated panel reactive antibody prior to cardiac transplantation. J Heart Lung Transplant 1999; 18:701-706.
19. Vo AA, Lukovsky M, Toyoda M, et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008; 359:242-251.
20. Everly MJ, Everly JJ, Susskind B, et al. Bortezomib provides effective therapy for antibody-and cell-mediated acute rejection. Transplantation 2008; 86:1754-1761.
21. Patel J, Everly M, Chang D, et al. Reduction of alloantibodies via proteosome inhibition in cardiac transplantation. J Heart Lung Transplant 2011; 30:1320-1326.